Company Profile

KWALITY PHARMACEUTICALS LTD.

NSE : NABSE : 539997ISIN CODE : INE552U01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE857.7040.8 (+4.99 % )
PREV CLOSE (Rs.) 816.90
OPEN PRICE (Rs.) 857.70
BID PRICE (QTY) 813.15 (3000 )
OFFER PRICE (QTY) 857.70 (3000 )
VOLUME 24000
TODAY'S LOW / HIGH (Rs.)853.95 857.70
52 WK LOW / HIGH (Rs.) 48 922.8
NSE
This Company is not listed in NSE

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 0.00
TTM EPS (Rs.) 14.86
P/E Ratio 57.55
Book Value (Rs.) 44.62
Face Value (Rs.) 10
MCap (Rs. in Mn) 8871.65
Price/Earning (TTM) 40.60
Price/Sales (TTM) 3.39
Price/Book (MRQ) 19.16
PAT Margin (%) 6.08
ROCE (%) 18.56
Incorporation Year : 1983

Management Info :

- Chairman Ramesh Arora - Managing Director

Registered Office :

Address : Village Nagkalan,Majitha Road,,
Amritsar,
Punjab-143601

Phone : 8558820862

Registrar's Details : Bigshare Services Pvt Ltd
Bharat Tin Works Building,1st floor, Opp. Vasant Oasis,Andheri (E),Mumbai
Listing : BSE
NEWS More
13Oct10-13-2021$ Board Meeting Intimation for For Considering Unaudited Financial Results For The Half Year Ended On 30Th September, 2021 Board Meeting Intimation fo
Kwality Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/10/2021 ,inter alia, to consider and approve the Standalone and Consolidated Unaudited Financial Results of the Company for the half year ended on 30th September, 2021
Kwality Pharmaceuticals Ltdhas informed BSE that the meeting of..
08Sep09-08-2021$Kwality Pharmaceuticals informs about annual report Kwality Pharmaceuticals info
Pursuant to Regulation 34(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Kwality Pharmaceuticals has informed that it enclosed copy of Annual Report for the Financial Year 2020-21 along with notice convening the 38th Annual General Meeting of the members of the Company.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 34(1) of SEBI (Listing Obligations and D..
26Jun06-26-2021$Kwality Pharmaceuticals informs about disclosure Kwality Pharmaceuticals info

Kwality Pharmaceuticals has informed that the Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ways Vinimay.

The above information is a part of company’s filings submitted to BSE.

Kwality Pharmaceuticals has informed that the Exchange has rece..
Financials More
Rs. in Millions
QTR Mar 16 ANNUAL 21
Net Profit10.32154.15
Gross Profit 16.55 217.99
Operating Profit 32.49308.47
Net Sales 397.182615.03
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
NGL Fine-Chem (BSE)
 2644.00 (2.19%)
M.Cap ( in Cr)
1634.09
Jubilant Pharmova (BSE)
 654.10 (3.06%)
M.Cap ( in Cr)
10229.03
Source Natural Foods (BSE)
 132.65 (13.13%)
M.Cap ( in Cr)
82.91
Alkem Laboratories (BSE)
 3872.75 (0.27%)
M.Cap ( in Cr)
45787.42
Lincoln Pharma (BSE)
 384.90 (2.33%)
M.Cap ( in Cr)
768.80
Shareholding Pattern More
PROMOTERS 54.13 %
NON-INSTITUTION 45.87 %
MUTUAL FUNDS/UTI 0 %
FI/BANKS/INSURANCE 0 %
GOVERNMENT 0 %
FII 0 %
MF HOLDINGS
Scheme NameHold(%)
No Data Found
F & O Quotes